Lee's Pharmaceutical to Distribute PAH Drug in China

Published: Jul 22, 2010

ChinaBio Today -- Lee's Pharmaceutical, which is headquartered in Hong Kong, will be the exclusive China distributor for Remodulin, a United Therapeutics product. Remodulin is a prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee's Pharma will be responsible for obtaining approval of the drug in China, which will include conducting bridging studies. More details....

Back to news